Information Journal Paper
APA:
Copy. (2017). Everolimus in patients with advanced follicular-derived thyroid cancer: results of a phase II clinical trial. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 102(2), 698-707. SID. https://sid.ir/paper/731823/en
Vancouver:
Copy. Everolimus in patients with advanced follicular-derived thyroid cancer: results of a phase II clinical trial. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM[Internet]. 2017;102(2):698-707. Available from: https://sid.ir/paper/731823/en
IEEE:
Copy, “Everolimus in patients with advanced follicular-derived thyroid cancer: results of a phase II clinical trial,” JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 102, no. 2, pp. 698–707, 2017, [Online]. Available: https://sid.ir/paper/731823/en